Products
-
Archive: EU Clinical Trial Regulation (EU-CTR) Requirements -
Archive: FDA Drug Approval Process -
Archive: FDA Medical Device Approval Process -
Archive: FDA Requirements for Electronic Source Data in Clinical Investigations -
Archive: FDA's Bioresearch Monitoring (BIMO) Program: Inspection of Sponsors, CROs, and Monitors -
Archive: FDA's Updated Informed Consent Guidance: What's New? -
Archive: Final AE Regulatory Guidance -
Archive: Final FDA Guidance: How to Complete the Form FDA 1572 -
Archive: Final ICH GCP E6 R2: Changes Impacting Clinical Investigators, Sites, and IND Holders (Sponsors-Investigators and Institutions) -
Archive: Five Key Strategic Steps for Developing Global SOPs -
Archive: Fraud in Clinical Research: An Overview -
Archive: GCP Renovation (ICH E8 R1 and ICH E6 R3) -
Archive: GCP Training for Investigators -
Archive: Good Clinical Practice (GCP) for Medical Devices: ICH GCP E6 and ISO 14155 -
Archive: Good Clinical Practice: Practical Application and Implementation -
Archive: HIPAA Team Training: Fundamental Training Specifically for Clinical Research Settings -
Archive: ICH E6 (R3) Draft: A Discussion -
Archive: ICH E6(R3) and ICH E8(R1) Updates: Impact on Sponsors -
Archive: ICH E8 (R1): Changes Impacting Sponsors/CROs -
Archive: ICH E8 (R1): Designing Quality into Clinical Studies -
Archive: ICH GCP E6 R2 and R3 Updates: Implementing Risk Management Approaches for Compliance -
Archive: ICH GCP E6(R3) Updates: Impact on Clinical Data Management -
Archive: ICH GCP E6(R3) Updates: Key Changes Impacting Sponsors and CROs -
Archive: ICH GCP E6(R3) Updates: Overview of Changes Impacting Sponsors, CROs, and Clinical Investigators/Sites